Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) randomized controlled trial: a systematic review of published responses

被引:11
作者
Williams, Norman R. [1 ]
Patrick, Hannah [2 ]
Fiorentino, Francesca [3 ]
Allen, Alexander [4 ]
Sharma, Manuj [5 ]
Milosevic, Misel [6 ]
Macbeth, Fergus [7 ]
Treasure, Tom [8 ]
机构
[1] UCL, Surg & Intervent Trials Unit, London, England
[2] South London Healthcare NHS Trust, London, England
[3] Kings Coll London, Nightingale Saunders Clin Trials & Epidemiol Unit, Kings Clin Trials Unit, London, England
[4] Royal Free London NHS Fdn Trust, London, England
[5] UCL, Res Dept Primary Care & Populat Hlth, London, England
[6] Inst Lung Dis Vojvodina, Thorac Surg Clin, Sremska Kamenica, Serbia
[7] Cardiff Univ, Ctr Trials Res, Cardiff, Wales
[8] UCL, Clin Operat Res Unit, 4 Taviton St, London WC1H 0BT, England
关键词
Pulmonary metastasectomy; Colorectal cancer; Randomised controlled trial; Motivated reasoning; Citation index; LUNG METASTASECTOMY; RADIOTHERAPY; SURVIVAL; SURGERY; BIOLOGY;
D O I
10.1093/ejcts/ezac253
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The objective of this review was to assess the nature and tone of the published responses to the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) randomized controlled trial. METHODS Published articles that cited the PulMiCC trial were identified from Clarivate Web of Science ((c). Duplicates and self-citations were excluded and relevant text was extracted. Four independent researchers rated the extracts independently using agreed scales for the representativeness of trial data and the textual tone. The ratings were aggregated and summarized. Two PulMiCC authors carried out a thematic analysis of the extracts. RESULTS Sixty-four citations were identified and relevant text was extracted and examined. The consensus rating for data inclusion was a median of 0.25 out of 6 (range 0-5.25, interquartile range 0-1.5) and, for textual tone, the median rating was 1.87 out of 6 (range 0-5.75, interquartile range 1-3.5). The majority of citations did not provide adequate representation of the PulMiCC data and the overall textual tone was dismissive. Although some were supportive, many discounted the findings because the trial closed early and was underpowered to show non-inferiority. Two misinterpreted the authors' conclusions but there was an acceptance that 5-year survival was much higher than widely assumed. CONCLUSIONS Published comments reveal a widespread reluctance to consider seriously the results of a carefully conducted randomized trial. This may be because the results challenge accepted practice because of 'motivated reasoning', but there is a widespread misunderstanding of the fact that though PulMiCC with 93 patients was underpowered to test non-inferiority, it still provides reliable evidence to undermine the widespread belief in a major survival benefit from metastasectomy. It ought to be remembered that there is nothing more difficult to take in hand, more perilous to conduct, or more uncertain in its success, than to take the lead in the introduction of a new order of things. .
引用
收藏
页数:10
相关论文
共 80 条
[1]   THE EFFECT OF METASTASECTOMY - FACT OR FICTION [J].
ABERG, T ;
MALMBERG, KA ;
NILSSON, B ;
NOU, E .
ANNALS OF THORACIC SURGERY, 1980, 30 (04) :378-384
[2]   Analysis of pulmonary metastasis as an indication for operation: an evidence-based approach [J].
Aberg, Torkel ;
Treasure, Tom .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 50 (05) :792-798
[3]   Surveillance Following Hepatic Resection for Colorectal Liver Metastases in Elderly Patients Systematic Review to Guide "When to Draw the Line" [J].
Alabraba, Edward ;
Gomez, Dhanny .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10) :552-552
[4]   Systematic Review of Treatments for Colorectal Metastases in Elderly Patients to Guide Surveillance Cessation Following Hepatic Resection for Colorectal Liver Metastases [J].
Alabraba, Edward ;
Gomez, Dhanny .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (05) :210-223
[6]   REPLY FROM AUTHOR: BIOLOGY IS KING, BUT METASTASECTOMY STILL HAS A ROLE FOR PROPERLY SELECTED PATIENTS [J].
Antonoff, Mara B. ;
Morris, Van K. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 162 (01) :E136-E138
[7]   The roles of surgery, stereotactic radiation, and ablation for treatment of pulmonary metastases [J].
Antonoff, Mara B. ;
Sofocleous, Constantinos T. ;
Callstrom, Matthew R. ;
Nguyen, Quynh-Nhu .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (02) :495-502
[8]   Multimodal and palliative treatment of patients with pulmonary metastases [J].
Baldes, Natalie ;
Eberlein, Michael ;
Bolukbas, Servet .
JOURNAL OF THORACIC DISEASE, 2021, 13 (04) :2686-2691
[9]   Pulmonary metastasectomy in colorectal carcinoma [J].
Beckers, Paul ;
Berzenji, Lawek ;
Yogeswaran, Suresh K. ;
Lauwers, Patrick ;
Bilotta, Giada ;
Shkarpa, Nikol ;
Hendriks, Jeroen ;
Van Schil, Paul E. .
JOURNAL OF THORACIC DISEASE, 2021, 13 (04) :2628-2635
[10]   Reply to: The PulMiCC Trial Provides Control Data for Colorectal Lung Metastases Amenable to Local Treatments [J].
Bhartia, Bobby ;
Zhong, Jim ;
Chaudhuri, Nilanjan ;
Milton, Richard ;
Smith, Jonathan ;
Lenton, James ;
Wah, Tze Min .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 44 (04) :656-657